Editors: Klaus Podar, Kenneth C. Anderson

Multiple Myeloma - A New Era of Treatment Strategies

eBook: US $29 Special Offer (PDF + Printed Copy): US $133
Printed Copy: US $119
Library License: US $116
ISBN: 978-1-60805-609-5 (Print)
ISBN: 978-1-60805-297-4 (Online)
Year of Publication: 2012
DOI: 10.2174/97816080529741120101

Introduction

Multiple Myeloma (MM), the second most common blood cancer in adults, is a clonal plasma cell malignancy within the bone marrow characterized by osteolytic bone lesions, renal disease, and immunodeficiency. It is now well established that MM cell- induced disruption of the bone marrow homeostasis between the highly organized cellular and extracellular compartments supports MM cell proliferation, survival, migration, and drug resistance via activation of various signaling pathways. Based on this knowledge, the prototypic drugs thalidomide, bortezomib, and lenalidomide, which target both MM cells and the bone marrow microenvironment, have already fundamentally changed treatment options of this disease. Indeed, their benefit is now not only shown in relapsed and refractory disease but they also improve overall response, duration of response, and progression-free and overall survival when used as part of first-line regimens. However, despite new insights into MM pathogenesis and exciting derived therapeutic advances, MM still remains incurable. Ongoing studies are therefore aiming to further delineate mechanisms of MM pathogenesis within the bone marrow to identify novel agents with enhanced cytotoxicity and decreased drug resistance to improve patient outcome.

Multiple Myeloma - A New Era of Treatment Strategies is devoted to contributions from eminent scientists providing readers with comprehensive accounts of the most recent developments in the field of MM research. It addresses the interests of scientists and clinical investigators in MM research as well as other fields of oncology, in which the microenvironment is believed to play an important role.

Indexed in: Book Citation Index, Science Edition, Web of Science, Scopus, EBSCO.

Foreword

The pace at which myeloma therapy has evolved in recent years has been nothing short of spectacular. Conventional textbooks can scarcely keep up with the advances. This electronic book edited by Dr. Klaus Podar and Kenneth Anderson is therefore both timely and appropriate. I would like to congratulate the editors for assembling a stellar cast of investigators to author the various chapters in this e-Book. The editors and authors have done a masterful job with the content and organization of the e-Book. I am sure this e Book will be an invaluable resource for physicians worldwide.

S. Vincent Rajkumar,
Mayo Clinic
USA


RELATED BOOKS

.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .
.Cutting Edge Therapies for Cancer in the 21 Century.